Table of Content

1 PPARδ Agonist Market Overview
1.1 Product Overview and Scope of PPARδ Agonist
1.2 PPARδ Agonist Segment by Type
1.2.1 Global PPARδ Agonist Market Value Comparison by Type (2024-2034)
1.2.2 GW0742
1.2.3 Lanifibranor
1.2.4 Elafibranor
1.3 PPARδ Agonist Segment by Application
1.3.1 Global PPARδ Agonist Market Value by Application: (2024-2034)
1.3.2 Cirrhosis
1.3.3 Nonalcoholic Steatohepatitis
1.3.4 Diabetes
1.3.5 Reduce Inflammation
1.3.6 Others
1.4 Global PPARδ Agonist Market Size Estimates and Forecasts
1.4.1 Global PPARδ Agonist Revenue 2024-2034
1.4.2 Global PPARδ Agonist Sales 2024-2034
1.4.3 Global PPARδ Agonist Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 PPARδ Agonist Market Competition by Manufacturers
2.1 Global PPARδ Agonist Sales Market Share by Manufacturers (2024-2024)
2.2 Global PPARδ Agonist Revenue Market Share by Manufacturers (2024-2024)
2.3 Global PPARδ Agonist Average Price by Manufacturers (2024-2024)
2.4 Global PPARδ Agonist Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of PPARδ Agonist, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PPARδ Agonist, Product Type & Application
2.7 PPARδ Agonist Market Competitive Situation and Trends
2.7.1 PPARδ Agonist Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest PPARδ Agonist Players Market Share by Revenue
2.7.3 Global PPARδ Agonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PPARδ Agonist Retrospective Market Scenario by Region
3.1 Global PPARδ Agonist Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global PPARδ Agonist Global PPARδ Agonist Sales by Region: 2024-2034
3.2.1 Global PPARδ Agonist Sales by Region: 2024-2024
3.2.2 Global PPARδ Agonist Sales by Region: 2024-2034
3.3 Global PPARδ Agonist Global PPARδ Agonist Revenue by Region: 2024-2034
3.3.1 Global PPARδ Agonist Revenue by Region: 2024-2024
3.3.2 Global PPARδ Agonist Revenue by Region: 2024-2034
3.4 North America PPARδ Agonist Market Facts & Figures by Country
3.4.1 North America PPARδ Agonist Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America PPARδ Agonist Sales by Country (2024-2034)
3.4.3 North America PPARδ Agonist Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe PPARδ Agonist Market Facts & Figures by Country
3.5.1 Europe PPARδ Agonist Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe PPARδ Agonist Sales by Country (2024-2034)
3.5.3 Europe PPARδ Agonist Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PPARδ Agonist Market Facts & Figures by Country
3.6.1 Asia Pacific PPARδ Agonist Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific PPARδ Agonist Sales by Country (2024-2034)
3.6.3 Asia Pacific PPARδ Agonist Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America PPARδ Agonist Market Facts & Figures by Country
3.7.1 Latin America PPARδ Agonist Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America PPARδ Agonist Sales by Country (2024-2034)
3.7.3 Latin America PPARδ Agonist Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PPARδ Agonist Market Facts & Figures by Country
3.8.1 Middle East and Africa PPARδ Agonist Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa PPARδ Agonist Sales by Country (2024-2034)
3.8.3 Middle East and Africa PPARδ Agonist Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PPARδ Agonist Sales by Type (2024-2034)
4.1.1 Global PPARδ Agonist Sales by Type (2024-2024)
4.1.2 Global PPARδ Agonist Sales by Type (2024-2034)
4.1.3 Global PPARδ Agonist Sales Market Share by Type (2024-2034)
4.2 Global PPARδ Agonist Revenue by Type (2024-2034)
4.2.1 Global PPARδ Agonist Revenue by Type (2024-2024)
4.2.2 Global PPARδ Agonist Revenue by Type (2024-2034)
4.2.3 Global PPARδ Agonist Revenue Market Share by Type (2024-2034)
4.3 Global PPARδ Agonist Price by Type (2024-2034)
5 Segment by Application
5.1 Global PPARδ Agonist Sales by Application (2024-2034)
5.1.1 Global PPARδ Agonist Sales by Application (2024-2024)
5.1.2 Global PPARδ Agonist Sales by Application (2024-2034)
5.1.3 Global PPARδ Agonist Sales Market Share by Application (2024-2034)
5.2 Global PPARδ Agonist Revenue by Application (2024-2034)
5.2.1 Global PPARδ Agonist Revenue by Application (2024-2024)
5.2.2 Global PPARδ Agonist Revenue by Application (2024-2034)
5.2.3 Global PPARδ Agonist Revenue Market Share by Application (2024-2034)
5.3 Global PPARδ Agonist Price by Application (2024-2034)
6 Key Companies Profiled
6.1 AbMole
6.1.1 AbMole Corporation Information
6.1.2 AbMole Description and Business Overview
6.1.3 AbMole PPARδ Agonist Sales, Revenue and Gross Margin (2024-2024)
6.1.4 AbMole PPARδ Agonist Product Portfolio
6.1.5 AbMole Recent Developments/Updates
6.2 Delta Bio
6.2.1 Delta Bio Corporation Information
6.2.2 Delta Bio Description and Business Overview
6.2.3 Delta Bio PPARδ Agonist Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Delta Bio PPARδ Agonist Product Portfolio
6.2.5 Delta Bio Recent Developments/Updates
6.3 Inventiva
6.3.1 Inventiva Corporation Information
6.3.2 Inventiva Description and Business Overview
6.3.3 Inventiva PPARδ Agonist Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Inventiva PPARδ Agonist Product Portfolio
6.3.5 Inventiva Recent Developments/Updates
6.4 RECHEM
6.4.1 RECHEM Corporation Information
6.4.2 RECHEM Description and Business Overview
6.4.3 RECHEM PPARδ Agonist Sales, Revenue and Gross Margin (2024-2024)
6.4.4 RECHEM PPARδ Agonist Product Portfolio
6.4.5 RECHEM Recent Developments/Updates
6.5 DMK
6.5.1 DMK Corporation Information
6.5.2 DMK Description and Business Overview
6.5.3 DMK PPARδ Agonist Sales, Revenue and Gross Margin (2024-2024)
6.5.4 DMK PPARδ Agonist Product Portfolio
6.5.5 DMK Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PPARδ Agonist Industry Chain Analysis
7.2 PPARδ Agonist Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PPARδ Agonist Production Mode & Process
7.4 PPARδ Agonist Sales and Marketing
7.4.1 PPARδ Agonist Sales Channels
7.4.2 PPARδ Agonist Distributors
7.5 PPARδ Agonist Customers
8 PPARδ Agonist Market Dynamics
8.1 PPARδ Agonist Industry Trends
8.2 PPARδ Agonist Market Drivers
8.3 PPARδ Agonist Market Challenges
8.4 PPARδ Agonist Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global PPARδ Agonist Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global PPARδ Agonist Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global PPARδ Agonist Market Competitive Situation by Manufacturers in 2022
Table 4. Global PPARδ Agonist Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global PPARδ Agonist Sales Market Share by Manufacturers (2024-2024)
Table 6. Global PPARδ Agonist Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global PPARδ Agonist Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market PPARδ Agonist Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of PPARδ Agonist, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of PPARδ Agonist, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of PPARδ Agonist, Product Type & Application
Table 12. Global Key Manufacturers of PPARδ Agonist, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PPARδ Agonist by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PPARδ Agonist as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PPARδ Agonist Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global PPARδ Agonist Sales by Region (2024-2024) & (K Units)
Table 18. Global PPARδ Agonist Sales Market Share by Region (2024-2024)
Table 19. Global PPARδ Agonist Sales by Region (2024-2034) & (K Units)
Table 20. Global PPARδ Agonist Sales Market Share by Region (2024-2034)
Table 21. Global PPARδ Agonist Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global PPARδ Agonist Revenue Market Share by Region (2024-2024)
Table 23. Global PPARδ Agonist Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global PPARδ Agonist Revenue Market Share by Region (2024-2034)
Table 25. North America PPARδ Agonist Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America PPARδ Agonist Sales by Country (2024-2024) & (K Units)
Table 27. North America PPARδ Agonist Sales by Country (2024-2034) & (K Units)
Table 28. North America PPARδ Agonist Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America PPARδ Agonist Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe PPARδ Agonist Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe PPARδ Agonist Sales by Country (2024-2024) & (K Units)
Table 32. Europe PPARδ Agonist Sales by Country (2024-2034) & (K Units)
Table 33. Europe PPARδ Agonist Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe PPARδ Agonist Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific PPARδ Agonist Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific PPARδ Agonist Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific PPARδ Agonist Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific PPARδ Agonist Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific PPARδ Agonist Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America PPARδ Agonist Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America PPARδ Agonist Sales by Country (2024-2024) & (K Units)
Table 42. Latin America PPARδ Agonist Sales by Country (2024-2034) & (K Units)
Table 43. Latin America PPARδ Agonist Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America PPARδ Agonist Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa PPARδ Agonist Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa PPARδ Agonist Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa PPARδ Agonist Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa PPARδ Agonist Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa PPARδ Agonist Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global PPARδ Agonist Sales (K Units) by Type (2024-2024)
Table 51. Global PPARδ Agonist Sales (K Units) by Type (2024-2034)
Table 52. Global PPARδ Agonist Sales Market Share by Type (2024-2024)
Table 53. Global PPARδ Agonist Sales Market Share by Type (2024-2034)
Table 54. Global PPARδ Agonist Revenue (US$ Million) by Type (2024-2024)
Table 55. Global PPARδ Agonist Revenue (US$ Million) by Type (2024-2034)
Table 56. Global PPARδ Agonist Revenue Market Share by Type (2024-2024)
Table 57. Global PPARδ Agonist Revenue Market Share by Type (2024-2034)
Table 58. Global PPARδ Agonist Price (US$/Unit) by Type (2024-2024)
Table 59. Global PPARδ Agonist Price (US$/Unit) by Type (2024-2034)
Table 60. Global PPARδ Agonist Sales (K Units) by Application (2024-2024)
Table 61. Global PPARδ Agonist Sales (K Units) by Application (2024-2034)
Table 62. Global PPARδ Agonist Sales Market Share by Application (2024-2024)
Table 63. Global PPARδ Agonist Sales Market Share by Application (2024-2034)
Table 64. Global PPARδ Agonist Revenue (US$ Million) by Application (2024-2024)
Table 65. Global PPARδ Agonist Revenue (US$ Million) by Application (2024-2034)
Table 66. Global PPARδ Agonist Revenue Market Share by Application (2024-2024)
Table 67. Global PPARδ Agonist Revenue Market Share by Application (2024-2034)
Table 68. Global PPARδ Agonist Price (US$/Unit) by Application (2024-2024)
Table 69. Global PPARδ Agonist Price (US$/Unit) by Application (2024-2034)
Table 70. AbMole Corporation Information
Table 71. AbMole Description and Business Overview
Table 72. AbMole PPARδ Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. AbMole PPARδ Agonist Product
Table 74. AbMole Recent Developments/Updates
Table 75. Delta Bio Corporation Information
Table 76. Delta Bio Description and Business Overview
Table 77. Delta Bio PPARδ Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Delta Bio PPARδ Agonist Product
Table 79. Delta Bio Recent Developments/Updates
Table 80. Inventiva Corporation Information
Table 81. Inventiva Description and Business Overview
Table 82. Inventiva PPARδ Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Inventiva PPARδ Agonist Product
Table 84. Inventiva Recent Developments/Updates
Table 85. RECHEM Corporation Information
Table 86. RECHEM Description and Business Overview
Table 87. RECHEM PPARδ Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. RECHEM PPARδ Agonist Product
Table 89. RECHEM Recent Developments/Updates
Table 90. DMK Corporation Information
Table 91. DMK Description and Business Overview
Table 92. DMK PPARδ Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. DMK PPARδ Agonist Product
Table 94. DMK Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. PPARδ Agonist Distributors List
Table 98. PPARδ Agonist Customers List
Table 99. PPARδ Agonist Market Trends
Table 100. PPARδ Agonist Market Drivers
Table 101. PPARδ Agonist Market Challenges
Table 102. PPARδ Agonist Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of PPARδ Agonist
Figure 2. Global PPARδ Agonist Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global PPARδ Agonist Market Share by Type in 2022 & 2034
Figure 4. GW0742 Product Picture
Figure 5. Lanifibranor Product Picture
Figure 6. Elafibranor Product Picture
Figure 7. Global PPARδ Agonist Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global PPARδ Agonist Market Share by Application in 2022 & 2034
Figure 9. Cirrhosis
Figure 10. Nonalcoholic Steatohepatitis
Figure 11. Diabetes
Figure 12. Reduce Inflammation
Figure 13. Others
Figure 14. Global PPARδ Agonist Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 15. Global PPARδ Agonist Market Size (2024-2034) & (US$ Million)
Figure 16. Global PPARδ Agonist Sales (2024-2034) & (K Units)
Figure 17. Global PPARδ Agonist Average Price (US$/Unit) & (2024-2034)
Figure 18. PPARδ Agonist Report Years Considered
Figure 19. PPARδ Agonist Sales Share by Manufacturers in 2022
Figure 20. Global PPARδ Agonist Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest PPARδ Agonist Players: Market Share by Revenue in 2022
Figure 22. PPARδ Agonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 23. Global PPARδ Agonist Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 24. North America PPARδ Agonist Sales Market Share by Country (2024-2034)
Figure 25. North America PPARδ Agonist Revenue Market Share by Country (2024-2034)
Figure 26. United States PPARδ Agonist Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 27. Canada PPARδ Agonist Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. Europe PPARδ Agonist Sales Market Share by Country (2024-2034)
Figure 29. Europe PPARδ Agonist Revenue Market Share by Country (2024-2034)
Figure 30. Germany PPARδ Agonist Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. France PPARδ Agonist Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. U.K. PPARδ Agonist Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Italy PPARδ Agonist Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Russia PPARδ Agonist Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Asia Pacific PPARδ Agonist Sales Market Share by Region (2024-2034)
Figure 36. Asia Pacific PPARδ Agonist Revenue Market Share by Region (2024-2034)
Figure 37. China PPARδ Agonist Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. Japan PPARδ Agonist Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. South Korea PPARδ Agonist Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. India PPARδ Agonist Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Australia PPARδ Agonist Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. China Taiwan PPARδ Agonist Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Southeast Asia PPARδ Agonist Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Latin America PPARδ Agonist Sales Market Share by Country (2024-2034)
Figure 45. Latin America PPARδ Agonist Revenue Market Share by Country (2024-2034)
Figure 46. Mexico PPARδ Agonist Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Brazil PPARδ Agonist Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Argentina PPARδ Agonist Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Middle East & Africa PPARδ Agonist Sales Market Share by Country (2024-2034)
Figure 50. Middle East & Africa PPARδ Agonist Revenue Market Share by Country (2024-2034)
Figure 51. Turkey PPARδ Agonist Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Saudi Arabia PPARδ Agonist Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 53. UAE PPARδ Agonist Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 54. Global Sales Market Share of PPARδ Agonist by Type (2024-2034)
Figure 55. Global Revenue Market Share of PPARδ Agonist by Type (2024-2034)
Figure 56. Global PPARδ Agonist Price (US$/Unit) by Type (2024-2034)
Figure 57. Global Sales Market Share of PPARδ Agonist by Application (2024-2034)
Figure 58. Global Revenue Market Share of PPARδ Agonist by Application (2024-2034)
Figure 59. Global PPARδ Agonist Price (US$/Unit) by Application (2024-2034)
Figure 60. PPARδ Agonist Value Chain
Figure 61. PPARδ Agonist Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed